ALX Oncology Holdings Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	867	742	459	870	3,199	-
Market Cap Growth	-	61.50%	-47.23%	-72.79%	-	-
Enterprise Value	682	569	202	507	2,764	-4
PE Ratio	-4.61	-4.61	-3.72	-10.43	-62.79	-
PS Ratio	-	-	-	-	2706.15	-
PB Ratio	4.51	3.91	1.74	2.40	7.44	-
P/FCF Ratio	-5.64	-5.64	-5.07	-12.66	-83.47	-
P/OCF Ratio	-5.69	-5.69	-5.15	-12.78	-83.54	-
EV/Sales Ratio	-	-	-	-	2338.79	-0.75
EV/EBITDA Ratio	-3.59	-3.59	-1.65	-6.07	-61.03	0.19
EV/EBIT Ratio	-3.57	-3.57	-1.64	-6.07	-60.76	0.19
EV/FCF Ratio	-4.32	-4.32	-2.23	-7.37	-72.14	0.25
Debt / Equity Ratio	0.05	0.05	0.04	-	-	-0.08
Debt / EBITDA Ratio	-0.06	-0.06	-0.08	-	-	-0.29
Debt / FCF Ratio	-0.07	-0.07	-0.10	-	-	-0.37
Quick Ratio	5.08	5.08	9.40	23.78	69.99	1.92
Current Ratio	5.24	5.24	9.57	24.00	70.28	1.97
Asset Turnover	0	0	0	0	0.01	0.44
Interest Coverage	-101.75	-101.75	-517.56	-6420.85	-	-913.71
Return on Equity (ROE)	-79.30%	-79.30%	-40.80%	-21.20%	-39.10%	38.00%
Return on Assets (ROA)	-65.20%	-65.20%	-37.00%	-20.40%	-22.40%	-213.10%
Return on Capital (ROIC)	-85.42%	-85.42%	-46.71%	-23.01%	-10.16%	29.41%
Earnings Yield	-18.80%	-21.68%	-26.88%	-9.59%	-1.59%	-
FCF Yield	-15.39%	-17.75%	-19.74%	-7.90%	-1.20%	-
Buyback Yield / Dilution	-5.62%	-5.62%	-0.97%	-118.05%	-500.86%	-11.84%
Total Shareholder Return	-5.62%	-5.62%	-0.97%	-118.05%	-500.86%	-11.84%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).